BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Brims F, Popowicz N, Rosenstengel A, Hart J, Yogendran A, Read CA, Lee F, Shrestha R, Franke A, Lewis JR, Kay I, Waterer G, Lee YCG. Bacteriology and clinical outcomes of patients with culture-positive pleural infection in Western Australia: A 6-year analysis. Respirology 2019;24:171-8. [PMID: 30187976 DOI: 10.1111/resp.13395] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Porcel JM. PILOTing towards a RAPID predictor of mortality for infectious pleural effusions. Eur Respir J 2020;56:2002425. [PMID: 33243775 DOI: 10.1183/13993003.02425-2020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Chen Z, Cheng H, Cai Z, Wei Q, Li J, Liang J, Zhang W, Yu Z, Liu D, Liu L, Zhang Z, Wang K, Yang L. Identification of Microbiome Etiology Associated With Drug Resistance in Pleural Empyema. Front Cell Infect Microbiol 2021;11:637018. [PMID: 33796482 DOI: 10.3389/fcimb.2021.637018] [Reference Citation Analysis]
3 Porcel JM, Ferreiro L, Rumi L, Espino-Paisán E, Civit C, Pardina M, Schoenenberger-Arnaiz JA, Valdés L, Bielsa S. Two vs. three weeks of treatment with amoxicillin-clavulanate for stabilized community-acquired complicated parapneumonic effusions. A preliminary non-inferiority, double-blind, randomized, controlled trial. Pleura Peritoneum 2020;5:20190027. [PMID: 32934974 DOI: 10.1515/pp-2019-0027] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Hjertman J, Bläckberg J, Ljungquist O. 16S rRNA is a valuable tool in finding bacterial aetiology of community-acquired pleural empyema-a population-based observational study in South Sweden. Infect Dis (Lond) 2021;:1-7. [PMID: 34606399 DOI: 10.1080/23744235.2021.1985165] [Reference Citation Analysis]
5 Gupta K, Stuewe E, Barry M. Asymptomatic man with an incidental finding of a massive empyema. BMJ Case Rep 2020;13:e237178. [PMID: 32913067 DOI: 10.1136/bcr-2020-237178] [Reference Citation Analysis]
6 Hassan M, Patel S, Sadaka AS, Bedawi EO, Corcoran JP, Porcel JM. Recent Insights into the Management of Pleural Infection. Int J Gen Med 2021;14:3415-29. [PMID: 34290522 DOI: 10.2147/IJGM.S292705] [Reference Citation Analysis]
7 Cargill TN, Hassan M, Corcoran JP, Harriss E, Asciak R, Mercer RM, McCracken DJ, Bedawi EO, Rahman NM. A systematic review of comorbidities and outcomes of adult patients with pleural infection. Eur Respir J 2019;54:1900541. [PMID: 31391221 DOI: 10.1183/13993003.00541-2019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
8 Popowicz ND, Piccolo F, Yap E, Wong C, Brockway B, Smith NA, Sullivan C, Musk AW, Lee YCG. Long-term follow-up after intrapleural tPA/DNase therapy for pleural infection. Respirology 2021;26:388-91. [PMID: 33590570 DOI: 10.1111/resp.14015] [Reference Citation Analysis]
9 Addala DN, Bedawi EO, Rahman NM. Parapneumonic Effusion and Empyema. Clin Chest Med 2021;42:637-47. [PMID: 34774171 DOI: 10.1016/j.ccm.2021.08.001] [Reference Citation Analysis]